315 related articles for article (PubMed ID: 35543945)
41. Ethanol extract of Herpetospermum caudigerum Wall ameliorates psoriasis-like skin inflammation and promotes degradation of keratinocyte-derived ICAM-1 and CXCL9.
Zhong Y; Zhang BW; Li JT; Zeng X; Pei JX; Zhang YM; Yang YX; Li FL; Deng Y; Zhao Q
J Integr Med; 2023 Nov; 21(6):584-592. PubMed ID: 37989697
[TBL] [Abstract][Full Text] [Related]
42. Anti-psoriasis effect of water-processed rosin in mice.
Li XQ; Chen Y; Zhou HM; Shi HL; Yan XN; Lin LP; Tan RX
J Ethnopharmacol; 2019 Oct; 242():112073. PubMed ID: 31288049
[TBL] [Abstract][Full Text] [Related]
43. Cudraxanthone D Ameliorates Psoriasis-like Skin Inflammation in an Imiquimod-Induced Mouse Model via Inhibiting the Inflammatory Signaling Pathways.
Kim N; Lee S; Kang J; Choi YA; Jang YH; Jeong GS; Kim SH
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641629
[TBL] [Abstract][Full Text] [Related]
44. Glycyrrhizin improves the pathogenesis of psoriasis partially through IL-17A and the SIRT1-STAT3 axis.
Qiong H; Han L; Zhang N; Chen H; Yan K; Zhang Z; Ma Y; Xu J
BMC Immunol; 2021 May; 22(1):34. PubMed ID: 34044769
[TBL] [Abstract][Full Text] [Related]
45. Deucravacitinib and shikonin combination therapy ameliorates imiquimod-induced psoriasis in mice.
Xu L; Jiang Y; Xu F; Liu J; Jiang Y; Fang F; Luo L
Int J Immunopathol Pharmacol; 2024; 38():3946320241260262. PubMed ID: 38876119
[TBL] [Abstract][Full Text] [Related]
46. Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in mice.
Liu Z; Liu H; Xu P; Yin Q; Wang Y; Opoku YK; Yang J; Song L; Sun X; Zhang T; Yu D; Wang X; Ren G; Li D
Biomed Pharmacother; 2018 Dec; 108():1425-1434. PubMed ID: 30372845
[TBL] [Abstract][Full Text] [Related]
47. Acetyl-11-keto-β-boswellic acid inhibits the secretion of cytokines by dendritic cells via the TLR7/8 pathway in an imiquimod-induced psoriasis mouse model and in vitro.
Wang MX; Zhao JX; Meng YJ; Di TT; Xu XL; Xie XJ; Lin Y; Zhang L; Wang N; Li P; Wang Y
Life Sci; 2018 Aug; 207():90-104. PubMed ID: 29859222
[TBL] [Abstract][Full Text] [Related]
48. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis.
Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ
Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833
[TBL] [Abstract][Full Text] [Related]
49. Indirubin combined with umbilical cord mesenchymal stem cells to relieve psoriasis-like skin lesions in BALB/c mice.
Lu X; Wang H; Wang H; Xie F; Jiang C; Shen D; Zhang H; Yang J; Lin Y
Front Immunol; 2022; 13():1033498. PubMed ID: 36466901
[TBL] [Abstract][Full Text] [Related]
50. IL-33 contributes to disease severity in Psoriasis-like models of mouse.
Duan Y; Dong Y; Hu H; Wang Q; Guo S; Fu D; Song X; Kalvakolanu DV; Tian Z
Cytokine; 2019 Jul; 119():159-167. PubMed ID: 30913451
[TBL] [Abstract][Full Text] [Related]
51. Transient receptor potential ankyrin 1 (TRPA1) positively regulates imiquimod-induced, psoriasiform dermal inflammation in mice.
Zhou Y; Han D; Follansbee T; Wu X; Yu S; Wang B; Shi Z; Domocos DT; Carstens M; Carstens E; Hwang ST
J Cell Mol Med; 2019 Jul; 23(7):4819-4828. PubMed ID: 31111624
[TBL] [Abstract][Full Text] [Related]
52. Topical VX-509 attenuates psoriatic inflammation through the STAT3/FABP5 pathway in keratinocytes.
Yan B; Liu P; Yi X; Li J; Liu N; Zhu W; Kuang Y; Chen X; Peng C
Pharmacol Res; 2022 Aug; 182():106318. PubMed ID: 35728766
[TBL] [Abstract][Full Text] [Related]
53. 2'-fucosyllactose inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response via the STAT3 signaling pathway.
Lei K; Wang D; Lin L; Zeng J; Li Y; Zhang L; Lane JA; Zuo D; Sun L
Int Immunopharmacol; 2020 Aug; 85():106659. PubMed ID: 32544868
[TBL] [Abstract][Full Text] [Related]
54. Thalidomide Improves Psoriasis-like Lesions and Inhibits Cutaneous VEGF Expression without Alteration of Microvessel Density in Imiquimod- induced Psoriatic Mouse Model.
Liu JH; Wu HH; Zhao YK; Wang F; Gao Q; Luo DQ
Curr Vasc Pharmacol; 2018; 16(5):510-521. PubMed ID: 28982338
[TBL] [Abstract][Full Text] [Related]
55. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice.
Sun J; Zhao Y; Hu J
PLoS One; 2013; 8(6):e67078. PubMed ID: 23825622
[TBL] [Abstract][Full Text] [Related]
56. Suppressive effect of β, β-dimethylacryloyl alkannin on activated dendritic cells in an imiquimod-induced psoriasis mouse model.
Wang Y; Zhao J; Zhang L; Di T; Liu X; Lin Y; Zeng Z; Li P
Int J Clin Exp Pathol; 2015; 8(6):6665-73. PubMed ID: 26261548
[TBL] [Abstract][Full Text] [Related]
57. Comparative studies on mannan and imiquimod induced experimental plaque psoriasis inflammation in inbred mice.
Wu H; Ou J; Li K; Wang T; Nandakumar KS
Clin Exp Immunol; 2023 Mar; 211(3):288-300. PubMed ID: 36645209
[TBL] [Abstract][Full Text] [Related]
58. Centella asiatica alleviates psoriasis through JAK/STAT3-mediated inflammation: An in vitro and in vivo study.
Lin P; Shi HY; Lu YY; Lin J
J Ethnopharmacol; 2023 Dec; 317():116746. PubMed ID: 37295572
[TBL] [Abstract][Full Text] [Related]
59. Fucosylation deficiency enhances imiquimod-induced psoriasis-like skin inflammation by promoting CXCL1 expression.
Li N; Lee Y; Suh JH; Oh JH; Jin SP; Lee DH; Chung JH
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166988. PubMed ID: 38070583
[TBL] [Abstract][Full Text] [Related]
60. Anti-inflammatory effects of a methanol extract of Dictamnus dasycarpus Turcz. root bark on imiquimod-induced psoriasis.
Choi M; Yi JK; Kim SY; Ryu JH; Lee J; Kwon W; Jang S; Kim D; Kim M; Kim H; Kim SH; Choi SK; Ryoo ZY
BMC Complement Altern Med; 2019 Dec; 19(1):347. PubMed ID: 31791315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
